4Molloy S,McKeith IG,O'Brien JT,et al.The role of levodopa in the management of dementia with bodies.J Neurol Neurosurg Psychiatry,2005,76(9):1200-1203.
5Pakrasi S,Thomas A,Mosimann UP,et al.Cholinesterase inhibitors in advanced Dementia with Lewy bodies:increase or stop.Int J Geriatr Psychiatry,2006,21(8):719-721.
二级参考文献14
1[1]McKeith IG,Galasko D,Kosaka K,et al.Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB):report of the consortium on DLB international workshop[J].Neurology,1996,47(5):1113-1124.
2[2]McKeith IG,Perry EK,Perry RH.Report of the second dementia with Lewy body international workshop:diagnosis and treatment.Consortium on Dementia with Lewy Bodies[J].Neurology,1999,22;53(5):902-905.
3[3]McKeith IG,Dickson DW,Lowe J,et al.Diagnosis and management of dementia with Lewy bodies:third report of the DLB Consortium[J].Neurology,2005,65(12):1863-1872.
4[4]McKeith IG.Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB):report of the Consortium on DLB International Workshop[J].J Alzheimers Dis,2006,9(3 Suppl):417-423.
5[5]Mosimann UP,Rowan EN,Partington CE,et al.Characteristics of visual hallucinations in Parkinson disease dementia and dementia with lewy bodies[J].Am J Geriatr Psychiatry,2006,14(2):153-160.
6[6]McKeith IG,Rowan E,Askew K,et al.More severe functional impairment in dementia with lewy bodies than Alzheimer disease is related to extrapyramidal motor dysfunction[J].Am J Geriatr Psychiatry,2006,14(7):582-588.
7[7]Tam CW,Burton EJ,McKeith IG,et al.Temporal lobe atrophy on MRI in Parkinson disease with dementia:a comparison with Alzheimer disease and dementia with Lewy bodies[J].Neurology,2005,64(5):861-865.
8[8]Cousins DA,Burton E J,Burn D,et al.Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer's disease:an MRI study[J].Neurology,2003,61(9):1191-1195.
9[9]Colloby SJ,Williams ED,Bum DJ,et al.Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT[J].Eur J Nucl Med Mol Imaging,2005,32(10):1176-1185.
10[10]O'Brien JT,Colloby S,Fenwick J,et al.Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies[J].Arch Neurol,2004,61 (6):919-925.
10Querfurth HW,Allam GJ,Geffroy MA,et al.Acetylcholinesterase inhibition in dementia with Lewy bodies:Results of a prospective Pilot trial[J]. Dementia Geriatr Cogn Disord,2000,11:314-321.
